Takeda vaccine manufacturing facility in Singen

Short description

Takeda W35 + W36 vaccine manufacturing facility in Singen

The project

A firm with a long history, Takeda Pharmaceutical Company Ltd is a research-based pharmaceutical company with operations worldwide. Takeda has invested some 120 million euros into production facilities in Singen for vaccine to protect against the dengue virus.

Services in detail

Implenia built the basic structure, which contained some 90,000 square metres of enclosed space divided up into a two-storey and a five-storey building. 

Challenges

• Creation of different storey heights through successive adaptation of the formwork
• High level of reinforcement in the shaft corner regions

Sustainability

High demands relating to occupational safety – no major occupational accidents